Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

NCT04003792 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastasis Colon Cancer

Interventions

DRUG: oxaliplatin
DRUG: FOLFIRI Protocol
DRUG: Bevacizumab

Sponsor

Rabin Medical Center